Ett nytt 5-H-bensodiazepinderivat, farmaceutiska kompositione r innehållande detsamma, förfarande för framställning av detta samt användning därav

The invention relates to the new 1-(3-chlorophenyl)-4-hydroxymethyl-7,8-dimethoxy-5H-2,3-benzodiazepine of formula (I) (I) and pharmaceutically acceptable acid addition salts thereof, furthermore to a process for preparing these compounds. The compounds according to the invention possess valuable an...

Full description

Saved in:
Bibliographic Details
Main Authors GABOR ZOLYOMI, MARTA RUSZ, FERENC ANDRASI, TAMAS HAMORI, PETER BOTKA, EVA TOMORI, IMRE MORAVCSIK, GYULA HORVATH, KATALINA GOLDSCHMIDT, JENO KOROESI
Format Patent
LanguageSwedish
Published 08.12.1997
Edition6
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to the new 1-(3-chlorophenyl)-4-hydroxymethyl-7,8-dimethoxy-5H-2,3-benzodiazepine of formula (I) (I) and pharmaceutically acceptable acid addition salts thereof, furthermore to a process for preparing these compounds. The compounds according to the invention possess valuable anxiolytic, antiaggressive and antidepressant effects and have at the same time favorable acute toxicity values, so they can be used to advantage in therapy.
Bibliography:Application Number: SE19910003022